London · Delayed Price · Currency is GBP · Price in GBX Aptamer Group Company Description
Aptamer Group PLC, together with its subsidiaries, provides binders for research, diagnostics, and therapeutics in the United Kingdom, rest of Europe, the United States, and internationally.
The company offers Optimer, a platform that enables the discovery and development of optimized DNA and RNA aptamers; and Optimer +, a platform that discovers and develops of hybrid DNA-protein molecules that combines the features of Optimer and antibodies.
It serves bioprocessing and diagnostic institutes, as well as pharmaceutical scientists. The company has strategic partnership with Unilever for the development of Optimer for use in deodorant, Neuro-Bio to develop reagents for Alzheimer’s disease test, and other pharma partner and AztraZeneca for drug delivery vehicle for fibrotic liver.
The company was founded in 2008 and is headquartered in York, the United Kingdom.
| Country | United Kingdom |
| Founded | 2008 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 34 |
| CEO | Arron Tolley |
Contact Details
Address: Windmill House York, YO10 5BR United Kingdom | |
| Phone | 44 19 0421 7404 |
| Website | aptamergroup.com |
Stock Details
| Ticker Symbol | APTA |
| Exchange | London Stock Exchange AIM |
| Fiscal Year | July - June |
| Reporting Currency | GBP |
| ISIN Number | GB00BNRRP542 |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Arron Tolley | Chief Executive Officer |
| Andrew Rapson | Chief Financial Officer |